Marie-Christine Vantyghem, Eric Mirallié, Abdallah Al-Salameh, Sébastien Aubert, Sara Barraud, Gregory Baud, Adrien Ben Hamou, Jean-Philippe Bertocchio, Françoise Borson-Chazot, Benjamin Bouillet, Claire Briet, Camille Buffet, Robert Caiazzo, Catherine Cardot-Bauters, Bertrand Cariou, Olivier Chabre, Philippe Chanson, Judith Charbit, Nathalie Chéreau, Benjamin Chevalier, Cédric Cirenei, Lucie Coppin, Bernard Corvillain, Niki Christou, Thomas Cuny, Désirée Deandreis, Sophie Deguelte, Brigitte Delemer, Rachel Desailloud, Christine Do Cao, Gianluca Donatini, Delphine Drui, Margot Dupeux, Stéphanie Espiard, Lucile Figueres, Samuel Frey, Edouard Ghanassia, Cecile Ghander, Sebastien Gaujoux, Bernard Goichot, Lionel Groussin, Iva Gueorguieva, Carole Guérin, Julien Hadoux, Magalie Haissaguerre, Héloise Henry, Elif Hindié, Pascal Houiller, Arnaud Jannin, Véronique Kerlan, Marc Klein, Eugénie Koumakis, Paulina Kuczma, Miriam Ladsous, Hélène Lasolle, Maëlle Le Bras, Anne-Lise Lecoq, Madleen Lemaitre, Jean-Christophe Lifante, Agnès Linglart, Antoine Guy Lopez, Charlotte Lussey-Lepoutre, Dominique Luton, Luigi Maione, Camille Marciniak, Muriel Mathonnet, Fabrice Menegaux, Arnaud Molin, Helena Mosbah, Claire Nominé-Criqui, Marie-Françoise Odou, David Osman, Nunza Cinzia Paladino, Clotilde Picart, Pauline Romanet, Nicolas Santucci, Nicolas Scheyer, Frédéric Sebag, Emmanuelle Sokol, David Taieb, Igor Tauveron, Christophe Tresallet, Frédéric Triponez, Bruno Vergès, Delphine Vezzosi, Laurent Brunaud, Kamenicky Peter
{"title":"French expert consensus statement on diagnosis and MANAGEMENT of PRIMARY HYPERPARATHYROIDISM.","authors":"Marie-Christine Vantyghem, Eric Mirallié, Abdallah Al-Salameh, Sébastien Aubert, Sara Barraud, Gregory Baud, Adrien Ben Hamou, Jean-Philippe Bertocchio, Françoise Borson-Chazot, Benjamin Bouillet, Claire Briet, Camille Buffet, Robert Caiazzo, Catherine Cardot-Bauters, Bertrand Cariou, Olivier Chabre, Philippe Chanson, Judith Charbit, Nathalie Chéreau, Benjamin Chevalier, Cédric Cirenei, Lucie Coppin, Bernard Corvillain, Niki Christou, Thomas Cuny, Désirée Deandreis, Sophie Deguelte, Brigitte Delemer, Rachel Desailloud, Christine Do Cao, Gianluca Donatini, Delphine Drui, Margot Dupeux, Stéphanie Espiard, Lucile Figueres, Samuel Frey, Edouard Ghanassia, Cecile Ghander, Sebastien Gaujoux, Bernard Goichot, Lionel Groussin, Iva Gueorguieva, Carole Guérin, Julien Hadoux, Magalie Haissaguerre, Héloise Henry, Elif Hindié, Pascal Houiller, Arnaud Jannin, Véronique Kerlan, Marc Klein, Eugénie Koumakis, Paulina Kuczma, Miriam Ladsous, Hélène Lasolle, Maëlle Le Bras, Anne-Lise Lecoq, Madleen Lemaitre, Jean-Christophe Lifante, Agnès Linglart, Antoine Guy Lopez, Charlotte Lussey-Lepoutre, Dominique Luton, Luigi Maione, Camille Marciniak, Muriel Mathonnet, Fabrice Menegaux, Arnaud Molin, Helena Mosbah, Claire Nominé-Criqui, Marie-Françoise Odou, David Osman, Nunza Cinzia Paladino, Clotilde Picart, Pauline Romanet, Nicolas Santucci, Nicolas Scheyer, Frédéric Sebag, Emmanuelle Sokol, David Taieb, Igor Tauveron, Christophe Tresallet, Frédéric Triponez, Bruno Vergès, Delphine Vezzosi, Laurent Brunaud, Kamenicky Peter","doi":"10.1016/j.ando.2025.102449","DOIUrl":null,"url":null,"abstract":"<p><p>In 2024, the French Society of Endocrinology, the French speaking association of endocrine surgery, and the French society of nuclear medicine have elaborated a joint consensus statement on primary hyperparathyroidism, which was presented at the last congress of the French Society of Endocrinology, in October 2024, and subsequently published as 15 individual chapters in the Annals of Endocrinology. This consensus statement is a fruit of a joint effort by over 80 French-speaking experts in the field, including adult and pediatric endocrinologists, endocrine and pediatric surgeons, radiologists, nuclear medicine specialists, biologists and geneticists, and has been endorsed by the Belgian and Swiss endocrine societies. This document summarizes the recommendations, subdivided into 15 sections each preceded by a brief introduction. It aimed at covering systematically all areas of diagnosis and management of primary hyperparathyroidism throughout life in a comprehensive way, that we hope could be useful in particular to our younger colleagues in training.</p>","PeriodicalId":93871,"journal":{"name":"Annales d'endocrinologie","volume":" ","pages":"102449"},"PeriodicalIF":2.9000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales d'endocrinologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.ando.2025.102449","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
In 2024, the French Society of Endocrinology, the French speaking association of endocrine surgery, and the French society of nuclear medicine have elaborated a joint consensus statement on primary hyperparathyroidism, which was presented at the last congress of the French Society of Endocrinology, in October 2024, and subsequently published as 15 individual chapters in the Annals of Endocrinology. This consensus statement is a fruit of a joint effort by over 80 French-speaking experts in the field, including adult and pediatric endocrinologists, endocrine and pediatric surgeons, radiologists, nuclear medicine specialists, biologists and geneticists, and has been endorsed by the Belgian and Swiss endocrine societies. This document summarizes the recommendations, subdivided into 15 sections each preceded by a brief introduction. It aimed at covering systematically all areas of diagnosis and management of primary hyperparathyroidism throughout life in a comprehensive way, that we hope could be useful in particular to our younger colleagues in training.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
